International Biotechnology (LON:IBT) Shares Cross Above Two Hundred Day Moving Average – Time to Sell?

International Biotechnology (LON:IBT)’s share price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 971.47 and traded as high as GBX 1,096.39. International Biotechnology shares last traded at GBX 1,085, with a volume of 102,357 shares.

International Biotechnology Stock Up 0.5%

The company has a quick ratio of 0.32, a current ratio of 0.11 and a debt-to-equity ratio of 9.43. The business has a 50-day moving average price of GBX 1,035.10 and a 200-day moving average price of GBX 971.47. The firm has a market capitalization of £345.33 million, a PE ratio of 4.49 and a beta of 0.52.

International Biotechnology (LON:IBT) last announced its quarterly earnings data on Tuesday, May 12th. The company reported GBX (4.83) EPS for the quarter. The company had revenue of GBX 24 million for the quarter. International Biotechnology had a return on equity of 27.35% and a net margin of 82.27%. Equities research analysts forecast that International Biotechnology will post 0.9435943 earnings per share for the current fiscal year.

About International Biotechnology

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.

The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.